CryptoPolyTech.com
Crypto, Politics, Tech, Gaming & World News.

GeoVax Labs Gets Notice of Allowance for US Patent Application Covering Marburg Vaccine | CPT PPP Coverage

 | cutline • press clip • news of the day |

Cryptopolytech (CPT) Public Press Pass (PPP)
News of the Day COVERAGE

200000048 – World Newser
•| #World |•| #Online |•| #Media |•| #Outlet |

View more Headlines & Breaking News here, as covered by cryptopolytech.com


GeoVax Labs Gets Notice of Allowance for US Patent Application Covering Marburg Vaccine appeared on www.marketscreener.com by MarketScreener.

GeoVax Labs, Inc. is a clinical-stage biotechnology company. The Company is focused on developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using its platforms. Its product pipeline includes ongoing human clinical trials for a COVID-19 and a gene-directed therapy against advanced head and neck cancers. It is developing a number of vaccines and immunotherapies for prevention or treatment of infectious diseases and cancers. Its product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02, GEO-EM01, GEO-LM01 and GEO-MM02. Its lead infectious disease candidate is GEO-CM04S1, a COVID-19 vaccine targeting high-risk immunocompromised patient populations. Its research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg and Lassa) and Zika virus, as well as immunotherapies for multiple solid tumors. Its wholly owned subsidiary is GeoVax, Inc.

More about the company

FEATURED ‘News of the Day’, as reported by public domain newswires.

Related Posts
Find more, like the above, right here on Cryptopolytech.com by following our extensive quiclick links appearing on images or [NEWSer CHEWSer].
View ALL Headlines & Breaking News here.

Source Information (if available)

This article originally appeared on www.marketscreener.com by MarketScreener – sharing via newswires in the public domain, repeatedly. News articles have become eerily similar to manufacturer descriptions.

We will happily entertain any content removal requests, simply reach out to us. In the interim, please perform due diligence and place any content you deem “privileged” behind a subscription and/or paywall.

CPT (CryptoPolyTech) PPP (Public Press Pass) Coverage features stories and headlines you may not otherwise see due to the manipulation of mass media.

We compile ‘news of the day’ content in an unbiased manner and contextually classify it to promote the growth of knowledge by sharing it just like GeoVax Labs Gets Notice of Allowance for US Patent Application Covering Marburg Vaccine

First to share? If share image does not populate, please close the share box & re-open or reload page to load the image, Thanks!

You might also like